Nuo Therapeutics, Inc.
AURX
Rank in Stocks
#22550
Nuo Therapeutics, Inc. operates as a regenerative medicine company,... Nuo Therapeutics, Inc. operates as a regenerative medicine company, specializing in the development, commercialization, and marketing of advanced cell-based technologies. These solutions are engineered to leverage the human body's inherent capacity for natural healing, with a primary focus on the United States market. Central to their offerings is a technology that isolates components from a patient's own blood (autologous) to generate a platelet-based therapy, specifically tailored for the treatment of chronic wounds. Established in Houston, Texas, in 1998, the company underwent a name change from Cytomedix, Inc. to Nuo Therapeutics, Inc. in November 2014.
Share Price
$1.07
Last synced: 2026-11-10
Market Cap
$51.80M
Change (1 day)
0.00%
Change (1 year)
-52.65%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nuo Therapeutics, Inc. (AURX)
Category
Healthcare
EPS for Nuo Therapeutics, Inc. (AURX)
EPS as of June 2026 TTM: $-0.04
According to Nuo Therapeutics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.04. At the end of 2025 the company had an EPS of $-0.05, equal to its 2024 EPS of $-0.05.
EPS history for Nuo Therapeutics, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.04 | -16.40% |
| 2025 | $-0.05 | 3.71% |
| 2024 | $-0.05 | -32.10% |
| 2023 | $-0.08 | -0.26% |
| 2022 | $-0.08 | 2,420.00% |
| 2021 | 0.00 | -44.44% |
| 2020 | $-0.01 | -90.95% |
| 2019 | $-0.06 | -9.82% |
| 2018 | $-0.07 | -93.51% |
| 2017 | $-1.02 | -145.13% |
| 2016 | $2.26 | -638.10% |
| 2015 | $-0.42 | 162.50% |
| 2014 | $-0.16 | -20.00% |
| 2013 | $-0.20 | -16.67% |
| 2012 | $-0.24 | 246.32% |
| 2011 | $-0.07 | -61.50% |
| 2010 | $-0.18 | 83.86% |
| 2009 | $-0.10 | -59.21% |
| 2008 | $-0.24 | 41.18% |
| 2007 | $-0.17 | 106.31% |
| 2006 | $-0.08 | -69.48% |
| 2005 | $-0.27 | -41.30% |
| 2004 | $-0.46 | 31.43% |
| 2003 | $-0.35 | 59.09% |
| 2002 | $-0.22 | -87.78% |
| 2001 | $-1.80 | -44.62% |
| 2000 | $-3.25 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.99 | 2,268.42% |
US
|
|
| $15.66 | -37,564.11% |
US
|
|
| $-7.07 | 16,813.88% |
US
|
|
| $-5.29 | 12,555.50% |
AU
|
|
| $12.88 | -30,913.64% |
BE
|
Questions about Nuo Therapeutics, Inc.'s earnings per share (EPS)
What is Nuo Therapeutics, Inc.'s earnings per share (EPS)?
Nuo Therapeutics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.04, as of Jun 2026.
What was Nuo Therapeutics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Nuo Therapeutics, Inc.'s earnings per share (EPS) was $-0.05, compared with $-0.05 in 2024.
How has Nuo Therapeutics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Nuo Therapeutics, Inc.'s earnings per share (EPS) was highest in 2021 (0.00) and lowest in 2023 ($-0.08).
How does Nuo Therapeutics, Inc.'s earnings per share (EPS) compare with similar companies?
Nuo Therapeutics, Inc.'s earnings per share (EPS) ($-0.04) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.